
Nuron Pharma Private Limited
About Nuron Pharma Private Limited
Data last updated:
Nuron Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 23 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2012PTC233353. Its GSTIN is 09AAECN4326K1Z9 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lokesh Kumar Tomar and Arvind Kumar Rana.
Its last annual general meeting (AGM) was held on 30 May 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at B – 11 Hardev Nagar Jharoda Burari, New Delhi, Delhi, India – 110084.
As per the financials filed for FY 2026, the company reported a revenue of ₹13.01 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹4,944 (net margin 0.4%) and EBITDA of ₹15,822 (EBITDA margin 1.2%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 3% over five years.
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nuron Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 11 Hardev Nagar Jharoda Burari, New Delhi, Delhi, India – 110084
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Nuron Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nuron Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Nuron Pharma Private Limited, buy the company report.
Financials of Nuron Pharma Private Limited
FY 2026 filings availableNuron Pharma Private Limited reported revenue of ₹13.01 Lakh (up 10% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue rose 10% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹13.01 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15,822 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,944 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nuron Pharma Private Limited, buy the company report.
Board of directors of Nuron Pharma Private Limited
Nuron Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lokesh Kumar Tomar | Director | 23 Mar 2012 | 14 Years 7 Months | Current |
| Arvind Kumar Rana | Director | 23 Mar 2012 | 14 Years 7 Months | Current |
Auditor
Nuron Pharma Private Limited is audited by KULDEEP SAURABH AND ASSOCIATES for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KULDEEP SAURABH AND ASSOCIATES | FY 2026 | 009930C |
Shareholding
The shareholding of Nuron Pharma Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nuron Pharma Private Limited, buy the company report.
Legal cases
Nuron Pharma Private Limited has 1 court case on record: 1 filed by Nuron Pharma. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against an individual | Disposed |
To see the full case history of Nuron Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nuron Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nuron Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECN4326K1Z9 | Uttar Pradesh | Active | 22 Jul 2017 |
To see the full GST registrations and return filing status of Nuron Pharma Private Limited, buy the company report.
Recent activity
Nuron Pharma Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Arvind Kumar Rana was appointed as Director on 23 Mar 2012.
Frequently asked questions
Nuron Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 23 March 2012 (14+ years old) and is registered under CIN U24232DL2012PTC233353.
Nuron Pharma has 2 current directors:
- Lokesh Kumar Tomar - Director
- Arvind Kumar Rana - Director
The latest financial statements of Nuron Pharma on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 May 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Nuron Pharma is 09AAECN4326K1Z9, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Nuron Pharma is U24232DL2012PTC233353. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nuron Pharma has 1 court case on record: 1 filed by the company.
Nuron Pharma was incorporated on 23 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Arvind Kumar Rana was appointed as Director on 23 Mar 2012. Lokesh Kumar Tomar was appointed as Director on 23 Mar 2012.
The registered office of Nuron Pharma is at B – 11 Hardev Nagar Jharoda Burari, New Delhi, Delhi, India – 110084.
Nuron Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.

